Ainos Inc
NASDAQ:AIMD
Ainos Inc
NASDAQ:AIMD
Price:
1.58
USD
-3.66%
Market Closed
Market Cap:
$11m
Relative Value
The Relative Value of one
AIMD
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.58 USD,
Ainos Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AIMD Relative Value
HIDDEN
Multiples Across Competitors
AIMD Competitors Multiples
Ainos Inc Competitors
Ainos Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Ainos Inc
NASDAQ:AIMD
|
11m USD | 97.6 | -0.7 | -2.2 | -1.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
415.6B USD | 6.8 | 98.9 | 16.2 | 22.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.5B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.3B USD | 6.2 | 21.6 | 13.4 | 16.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.7B USD | 10 | 30.5 | 23 | 24 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD | 5.7 | 18.1 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.1B AUD | 3.2 | 35.1 | 11.6 | 14.5 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.4B EUR | 11.2 | 36 | 39.2 | 40 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
